IDEX (IEX) Reports Q2 2025 Earnings Results
IDEX (IEX) reported Q2 2025 earnings with a 2% increase in organic orders and a 1% rise in organic sales, driven by growth in pharmaceutical, energy, and agriculture markets. Adjusted gross margin declined slightly, and adjusted EBITDA margin dropped to 27.4%, but free cash flow increased by 25% to $147 million.
Tickers: $IEX
Topics: cost savings earnings EBITDA free cash flow gross margin liquidity organic growth sales performance share repurchases